Assembly Biosciences, Inc.
ASMB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$9,196 | -$10,198 | -$8,818 | -$10,335 |
| Dep. & Amort. | $32 | $32 | $33 | $32 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $834 | $712 | $751 |
| Change in WC | -$7,217 | -$7,266 | -$15,077 | $9,385 |
| Other Non-Cash | $1,248 | -$160 | -$289 | -$240 |
| Operating Cash Flow | -$15,133 | -$16,758 | -$23,439 | -$407 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$42 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$180,929 | -$17,885 | -$19,846 | -$40,896 |
| Inv. Sales/Matur. | $22,700 | $34,500 | $26,432 | $34,200 |
| Other Inv. Act. | $0 | $379 | $0 | $0 |
| Investing Cash Flow | -$158,271 | $16,994 | $6,586 | -$6,696 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $171,932 | $357 | $1,922 | $16,899 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $96 |
| Financing Cash Flow | $171,932 | $357 | $1,922 | $16,995 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$1,472 | $593 | -$14,931 | $9,892 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $24,006 | $23,413 | $38,344 | $28,452 |
| End Cash | $22,534 | $24,006 | $23,413 | $38,344 |
| Free Cash Flow | -$15,175 | -$16,758 | -$23,439 | -$407 |